Ticker
ARDXCompany Name
ARDELYX INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 1.06B | $ 5.78M | $ 97.37M | $ 0 | -9.75% |
3/31/2025 | $ 1.31B | $ 6.4M | $ 48.7M | $ 0 | -4.21% |
12/31/2024 | $ 1.36B | $ 8.14M | $ 98.45M | $ 0 | -7.82% |
9/30/2024 | $ 1.39B | $ 7.63M | $ 75.64M | $ 0 | -5.99% |
6/30/2024 | $ 1.29B | $ 62.8M | $ 75.64M | $ 0 | -10.69% |
3/31/2024 | $ 1.59B | $ 72.71M | $ 75.64M | $ 0 | -9.34% |
12/31/2023 | $ 2.05B | $ 120.41M | $ 25.89M | $ 0 | -7.13% |
9/30/2023 | $ 916.94M | $ 139.09M | $ 0 | $ 0 | -15.17% |
6/30/2023 | $ 880.17M | $ 115.7M | $ 0 | $ 0 | -13.15% |
3/31/2023 | $ 1B | $ 116.74M | $ 9.58M | $ 0 | -12.59% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for ARDELYX INC is calculated as follows: (-1 * CF - Equity [ $ 156.65M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 519.83M ]
(=) Shareholder Yield [ -30.13% ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.56% |
median | 1.07% |
std | 11.12% |